Jaundice is a common problem in marrow transplant recipients. The incidence of bile duct obstruction in this setting is unknown. The purpose of this study was to determine the incidence of biliary obstruction, the causes, and outcomes following marrow transplant. Consecutive cases were reviewed at two major transplant centers in the United States from 1969 to 1996 at the Fred Hutchinson Cancer Research Center and 1989 to 1996 at the City of Hope National Medical Center. Nine cases of biliary obstruction were identified as a cause of jaundice in 7412 marrow transplant recipients, an incidence of 0.12%. The presentation was bimodal, with seven cases occurring prior to day 100 and two occurring 2 to 4 years after transplantation. The age distribution was 15 to 50 years and all patients had received allogeneic transplants. The causes of obstruction included gallbladder sludge (n‫,)1؍‬ a duodenal hematoma (n‫,)1؍‬ choledocholithiasis with biliary pancreatitis (n‫,)1؍‬ bile duct infection (n‫,)2؍‬ recurrent malignancy (n‫,)1؍‬ choledocholithiasis associated with a benign stricture (n‫,)1؍‬ Epstein-Barr virus-related lymphoproliferative disorder (n‫,)1؍‬ and a benign stricture of unknown etiology (n‫.)1؍‬ Biliary obstruction is a rare cause of jaundice in the post-transplant period. The presentation was similar to that of other post-transplant hepatobiliary problems, but with disparate causes.
The incidence of biliary obstruction as a cause of jaundice after hematopoietic cell transplant appears to be quite low. 1 Nonetheless, almost all jaundiced patients are evaluated for biliary obstruction because the therapeutic approach would be very different for ductal obstruction than for parenchymal liver diseases. In order to determine the incidence of biliary obstruction, we reviewed 7412 consecutive cases at two major marrow transplant centers. We sought to determine the causes of obstruction and whether the clinical presentation was in any way distinctive enough to allow these patients to be differentiated from those with much more common causes of jaundice.
Materials and methods

Techniques of hematopoietic cell transplantation
Patients undergoing transplantation receive a variety of combinations of chemotherapeutic agents and irradiation prior to the infusion of hematopoietic stem cells. The most commonly used regimens at the Fred Hutchinson Cancer Research Center (FHCRC) and the City of Hope have been described elsewhere. 2 Techniques of GVHD and microbial prophylaxis have changed over the 27 years encompassed by this report. [3] [4] [5] Patients are followed by our respective centers to day 100 and then by their local physicians.
Patient selection
We reviewed the medical records of all patients transplanted at the Fred Hutchinson Cancer Research Center from 1969 to 1996 and at the City of Hope National Medical Center from 1989 to 1996. Biliary obstruction was defined as persistent dilation of the common bile duct, common hepatic duct, or intrahepatic bile ducts, confirmed by ultrasound, CT X-ray, cholangiography (endoscopic, percutaneous, or surgical), or autopsy.
Clinical features of obstruction
We noted the timing of the onset of obstruction in relation to the day of transplantation, which by convention is termed day zero. Serum liver enzymes and total serum bilirubin at the time of presentation were noted, along with concomitant signs, symptoms, medications and transplant-related complications. The etiology of obstruction was determined by a review of imaging studies, microbiology, or histology of tissue specimens taken at surgery or autopsy. Persistent biliary obstruction is defined as that which is self-limited requiring some type of intervention for resolution.
Results
Incidence of biliary obstruction
Nine cases of persistent biliary obstruction developed among 7412 hematopoietic cell recipients (five of 6024 at the Fred Hutchinson Cancer Research Center and four of 1388 at the City of Hope National Medical Center), an incidence of 0.12%.
Clinical features and causes of obstruction
The demographic characteristics of the patients are shown in Table 1 , along with the liver tests at presentation and the causes of obstruction. All had a diagnosis of hematologic malignancy and all had received allogeneic hematopoietic cells after conditioning. Their age span (10-50 years) is representative of the transplant population at the two institutions. The timing of obstruction was bimodal, with seven cases presenting in the first 100 days after transplant and two cases presenting several years after transplant. Serum liver tests at the time of presentation were non-specifically elevated: mean values for AST, alkaline phosphatase, and total serum bilirubin were 134 IU/l, 409 IU/l, and 8.5 mg/dl, respectively. There were as many different causes of obstruction as there were patients. stone pancreatitis. Abdominal ultrasound revealed a 15 mm common bile duct. ERCP showed choledocholithiasis. Endoscopic sphincterotomy and extraction of a stone resulted in prompt resolution of jaundice. A repeat ultrasound 2 weeks later showed a normal diameter common bile duct at 6 mm.
Case 4: Cholangitis secondary to Cryptosporidium: UPN 900255 (COH) did well until day 26 when she developed crampy periumbilical and left lower quadrant pain associated with nausea and diarrhea. Colonoscopy was normal.
Abdominal pain improved over the next week but diarrhea persisted. Repeat colonoscopic biopsies on day 37 revealed acute GVHD and small, acid-fast 3-5 micron organisms adherent to the colonic epithelium, consistent with Cryptosporidium. Viral studies of colonic biopsy specimens were negative. Four days later, the patient was started on spiramycin. On that same day, she developed right upper quadrant abdominal pain, jaundice, and profuse diarrhea with worsening liver function tests. Abdominal ultrasound showed marked dilatation of the biliary tree (common bile duct 21 mm) without stones or sludge. An ERCP confirmed the presence of a markedly dilated, irregular common bile duct with a stricture in the distal common duct as well as intrahepatic ductal dilatation ( Figure 3) . A stent was placed across the stricture in the common bile duct. Bile was negative for Cryptosporidium and blood cultures were negative for CMV. Stool cultures became negative for Cryptosporidium at 8 months with eventual resolution of biliary dilatation after 1 year of treatment with spiramycin. prednisone therapy but began to deteriorate on day 52. On day 57, ganciclovir was started for a positive blood culture for cytomegalovirus (CMV). CT of the abdomen revealed a 20 mm common bile duct with sludge in the duct and the gallbladder. A percutaneous cholangiogram on day 67 (mainly visualizing the right hepatic system) showed multiple intra-and extrahepatic strictures (Figure 4a ). Placement of a percutaneous transbiliary stent into the duodenum resulted in a transient fall in bilirubin. Because of poor drainage through the percutaneous drains, an endoscopic sphincterotomy and balloon dilatation of two strictures in the common bile duct resulted in improvement (Figure 4b ). Although biopsies from the ampulla of Vater were negative for CMV as the patient was receiving ganciclovir, a clinical diagnosis of CMV cholangitis was made. Follow-up ultrasound and CT of the abdomen revealed resolution of biliary obstruction. The patient died on day 97, 27 days after sphincterotomy, from other complications. At autopsy, sections from the jejunum and colon revealed denuded mucosa and multiple thrombosed small vessels, suggestive of severe GVHD and previous CMV infection. The liver sections showed GVHD with a grossly normal biliary system.
Case 6: Chloroma: Seventy-six days after transplantation, UPN 891923 (COH) was admitted with anorexia and painless jaundice. Abdominal sonogram showed a thickened gallbladder but no stones or sludge. A radionuclide HIDA scan was consistent with intrahepatic cholestasis. Cyclosporine doses were decreased, but liver tests worsened. The patient was empirically treated with XomaZyme, a monoclonal anti-T cell antibody, for possible GVHD of the liver. Subsequently, a bone marrow biopsy showed evidence of cytogenetic relapse of his leukemia. An abdominal CT scan was done which revealed intrahepatic biliary dilatation in both the right and left lobes of the liver superior to the porta hepatis without any evidence of masses or lymphadenopathy. A percutaneous transhepatic cholangiogram showed complete obstruction of the right and left hepatic ducts near the porta hepatis. Drains were placed in the right and left hepatic ducts percutaneously. Following this pro- cedure, the patient became hypotensive. An emergency laparotomy found a hemoperitoneum secondary to bleeding from puncture sites in the capsule of the liver. A mass was present at the porta hepatis and biopsies were consistent with a chloroma. The patient died 48 h later from sepsis. Autopsy revealed extensive nodular leukemic infiltrates at the level of the bifurcation of the hepatic ducts and in several parts of the intestine. Because the endscopic guidewire could not be placed retrogradely through the stricture, a sphincterotomy and stent placement were performed in conjunction with a percutaneous transhepatic cholangiogram for immediate decompression of the biliary tree. Biopsies of the ampulla showed no viral inclusions. Ten days later, a Roux-en-Y side-toside choledochojejunostomy and a cholecystectomy were performed. Within the common bile duct were multiple small pigmented stones not seen on previous cholangiograms. Choledochoscopy revealed normal appearing mucosa in the area of the stricture but biopsies were not performed. Biopsies of the jejunum showed no evidence of GVHD. Subsequently, the patient did well.
Case 8: EBV-related lymphoproliferative disorder:
UPN 9299 (FHCRC) had an uneventful transplant course until 9 months later, when she developed intermittent abdominal pain, nausea, anorexia, occasional diarrhea, and abnormal liver tests. An abdominal ultrasound revealed a thickened gallbladder wall, a common bile duct of 9.5 mm but no gallstones. Upper endoscopy showed mild GVHD. ERCP showed mild common bile duct dilatation without filling abnormalities or obstruction. Because of persistently abnormal liver function tests, a CT scan was performed revealing adenopathy near the celiac axis and retroperitoneal adenopathy consistent with recurrent lymphoma. In spite of these findings, the patient refused treatment. Her liver function tests worsened and symptoms progressively worsened and at 1 year post transplant she presented with new onset jaundice and fever. Abdominal ultrasound revealed a thickened gallbladder wall and a common bile duct 11 mm in diameter but there was no evidence of gallstones. She underwent an open cholecystectomy with common bile duct exploration and liver biopsy. There was no evidence of choledocholithiasis or a mass obstructing the distal common bile duct. Pathologic examination of the gallbladder and liver biopsy revealed extensive infiltration of both organs with polymorphic immunoblastic cells which were EBV viral antigen LMP-1 positive. A small artery within the wall of the gallbladder was thrombosed. She died of rapidly progressive EBV lymphoproliferative disease, sepsis, and intestinal ischemia.
Case 9: Benign stricture: UPN 7953 (FHCRC) experienced early cytogenetic relapse of CML but did well for 3 years until she presented with a 7 to 10 day history of progressive jaundice, post-prandial, epigastric burning pain. An abdominal ultrasound was consistent with a common bile duct obstruction at the level of the head of the pancreas. There were no visible masses or gallstones in the duct or gallbladder. The proximal common bile duct measured 20 mm with intrahepatic ductal dilation; the distal common bile duct measured 6 mm. An ERCP showed a stricture in the common hepatic duct at the level of the cystic duct ( Figure 5) . Brushings of the area were negative for malignancy or infection. The patient underwent a choledochoduodenostomy for decompression of the biliary tree. Intraoperative biopsies of the stricture showed evidence of fibrosis and chronic inflammation but no malignant cells. Surrounding lymph nodes were also biopsied and were negative for malignancy. Her symptoms resolved and she has remained well for a year of follow-up.
Discussion
Ours is the largest reported series of biliary obstruction in marrow transplant recipients. Although there was no single cause, all cases were in some way related to the transplant process. We report four cases (cases 1, 3, 5, 7) of gallbladder sludge or stone-induced obstruction. Gallbladder sludge is common in the post-marrow transplant setting. [6] [7] [8] [9] [10] The sludge is composed mostly of calcium bilirubinate which forms for several reasons in these patients: (1) hypersecretion of mucus containing nucleating factors as a result of damage to gallbladder epithelium caused by cytoreductive therapy; (2) gallbladder stasis (largely related to the lack of enteral feeding and use of TPN); (3) increased bile pigment load from hemolysis and red blood cell transfusions. 6, 11 Prolonged administration of TPN can result in formation of pigment stones but usually after more than 2 years. 12 It is unlikely that the gallstones in the cases presented here were the result of short-term TPN administration, but the use of TPN may have contributed to the development of symptoms. Biliary sludge can be seen by ultrasound in up to 70% of patients at 4 weeks post transplant. 8, 9 Abnormal ultrasound findings of increased gallbladder wall thickness (Ͼ3 mm) and gallbladder dilation are also common. We have recognized a common clinical syndrome of abdominal pain, nausea, and vomiting caused by the emptying of gallbladder contents (sludge) into the duodenum, usually between days 25 and 50 post transplant. These signs and symptoms last 3-10 days in most patients. Cholecystitis and biliary obstruction with cholangitis are relatively uncommon in this setting 10 probably because bile flow can flush the microlithiasis into the duodenum. Indeed, in case 1 biliary obstruction proved to be transient, as attempts to increase bile flow were apparently successful. [13] [14] [15] [16] In cases 3, 5 and 7, gallbladder sludge and stones were more problematic. Case 3 developed pancreatitis and biliary obstruction from gallstones on day 32 post transplant, a time when most patients are resuming oral intake. Case 7 presented with obstruction secondary to a stricture and intraoperatively was found to have pigment stones in the common bile duct.
Papillitis with intra-and extrahepatic biliary strictures secondary to CMV has been reported in other immunocompromised patient populations but rarely in marrow transplant recipients. [17] [18] [19] [20] [21] In case 5, although CMV was never isolated from the biliary tree because of ganciclovir treatment, 22 the clinical and cholangiographic images were typical of CMV. In the past, CMV was a common opportunistic infection occurring in up to 60% of patients. 18 With the use of antiviral prophylaxis, the risk of CMV infection is now much less but not zero. CMV viremia tends to occur beyond 35 days post transplant and clinical manifestations of organ involvement follows 2 weeks later, on average.
Cryptosporidiosis of the biliary tree has been reported as a complication of AIDS. 20, 21 In spite of severe immunosuppression in the marrow transplant population, cholangitis due to cryptosporidiosis has not been previously reported. Case 4 had colitis secondary to cryptosporidium with intrahepatic biliary strictures that resolved after restoration of cell-mediated immunity and 1 year of treatment with spiramycin. The initial presentation of these two cases of infectious cholangitis was prior to day 50, a time when patients are most immunosuppressed and at the highest risk for opportunistic infection.
The formation of the duodenal hematoma following endoscopic biopsy was related to thrombocytopenia and the location of the biopsy site. Bleeding after duodenal biopsy has been described in children and in marrow transplant patients. 17 It is our current policy to avoid biopsies of the duodenum when we suspect GVHD, but rather to biopsy gastric mucosa. 23 The relatively rich blood supply from the gastroduodenal artery and its arcuate branches, the coagulopathy of marrow transplant patients and the friability of the duodenal wall in acute GVHD all contribute to the increased risk of hemorrhage after biopsy.
Two patients in this series, cases 7 and 9, developed biliary obstruction secondary to benign strictures. Neither patient had prior biliary tract surgery, chronic pancreatitis or external trauma. There are scattered reports of benign biliary strictures occurring after upper abdominal radiotherapy, 24 but not after total body irradiation. In case 9, the etiology was most likely ischemia based on the location and microscopic examination of the stricture. The blood supply to the mid-common bile duct arises from the cystic vessels proximally and the pancreatico-duodenal arcade distally and therefore is an area that is vulnerable to ischemic damage. 25 Case 7 likely represents a post-inflammatory stricture, an unusual but recognized complication of choledocholithiasis.
Leukemic relapse is typically detected via cytogenetic analysis of bone marrow specimens in patients with chronic myelogenous leukemia prior to overt signs of hematologic relapse. Case 6 developed obstructive jaundice due to a chloroma at the bifurcation of the hepatic ducts only 1 week after the diagnosis of cytogenetic relapse. This case has been previously reported in the radiology literature. 26 A similar case was described in which a patient transplanted for acute lymphocytic leukemia relapsed several months later with a chloroma in the head of the pancreas without evidence of hematologic relapse. 26, 27 Epstein-Barr virus (EBV)-related lymphoproliferative disorder leading to biliary obstruction was a late complication of marrow transplantation in case 8. This disorder occurs in marrow transplant recipients with severe GVHD receiving high-dose immunosuppressive therapy, and in those who have received a T cell-depleted marrow. Because of an impaired T cell response there may be uncontrolled proliferation of EBV-transformed B cells. 28 These abnormal B cells are capable of infiltrating any organ and can result in massive intra-abdominal lymphadenopathy. The etiology of biliary obstruction in case 8 was most likely due to tumor infiltration of the distal common bile duct. Unfortunately, as was the case in our patient, EBV-related lymphoproliferative disorder in the setting of GVHD is almost always fatal. 28 In the cases presented here, imaging tests showed biliary dilation, but more extensive invasive tests were needed to find the causes. There was no singular cause and the only common patient characteristic was that all had received an allogeneic transplant. The signs, symptoms, and laboratory tests in our patients could not be distinguished from those of other common hepatic diseases post transplant. Although routine abdominal ultrasonography in the evaluation of the jaundiced marrow transplant patient is a low-yield strategy, a missed diagnosis of biliary obstruction in this patient population may be catastrophic. In evaluating patients with unexplained jaundice post-marrow transplant, ultrasound remains a useful test.
